Premium
Cost‐utility of a six‐month programmed sports therapy ( PST ) in patients with haemophilia
Author(s) -
KoeberleinNeu J.,
Runkel B.,
Hilberg T.
Publication year - 2018
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.13459
Subject(s) - medicine , haemophilia , cost–utility analysis , haemophilia a , physical therapy , resource use , quality of life (healthcare) , cost effectiveness analysis , cost effectiveness , health care , quality adjusted life year , pediatrics , risk analysis (engineering) , nursing , natural resource economics , economics , economic growth
Recurrent musculoskeletal haemorrhages in people with haemophilia (PwH) lead to restrictions in the locomotor system and, as a result, in physical performance, too. Due to its physical and psychological benefits, sport is increasingly re‐commended for haemophilic patients. Evidence on the cost‐effectiveness of sports therapy is still lacking. Aim The aim of this study was to determine the cost‐effectiveness of a 6‐month programmed sports therapy ( PST ). Methods The cost‐effectiveness of the 6‐month PST was assessed from a societal perspective alongside a RCT using cost‐utility analysis. The analysis included 50 PwH with moderate‐to‐severe haemophilia A and B and a training period over 6 months. The health‐related quality of life was measured with the EuroQoL‐domain questionnaire. Resource utilization was assessed by questionnaire before and after the intervention. A cost‐effectiveness acceptability curve was constructed, and sensitivity analyses were performed. Results During the 6‐month study period, mean adjusted total healthcare costs were lower (mean difference: −22 805 EUR ; 95%‐ CI : −73 944‐48 463; P = .59) and the number of QALY s was higher in the intervention group (mean difference: 0.3733; 95%‐ CI : 0.0014‐0.0573; P = .04). The probability of an incremental cost‐effectiveness ratio <50 000 EUR per QALY was 71%. The performed sensitivity analysis confirmed these results. Conclusion Results showed that the PST is effective in terms of a significant gain of QALY s. Furthermore, results weakly indicate the potential of the PST to reduce healthcare costs. Future studies should expand the observation period to have a closer look at the influence of PST on lifetime costs.